Long-Acting GLP-1/GIP Dual Agonist Shows Weekly Dosing Potential in Healthy Cats
A pharmacokinetic study in 48 healthy cats found the GLP-1/GIP dual agonist HDM7006 has a roughly 44-hour half-life, dose-proportional exposure ...
Tag: HDM7006
POPULAR NEWS
-
Microbial Sources and Stress Shape the Hidden Endophytes of an Invasive Plant
-
Firebreaks Leave Lasting Scars in Grasslands While Wildfire Heals Fast
-
ZNF207 shields glutamine transporter ASCT2 from degradation to fuel liver cancer growth
-
Systematic review maps sustainability tensions in offshore wind development